| | Building Maryland’s BioHealth Future: Maryland Commerce’s Stefanie Trop on Growing the Life Sciences Sector | In this episode of BioTalk with Rich Bendis, Stefanie Trop, Ph.D., Director of Life Sciences at the Maryland Department of Commerce joins the conversation to discuss Maryland’s position as a leading life sciences hub. Stefanie shares how... | | |
There’s still time to showcase your organization at the region’s premier industry event. Sponsorship opportunities for BioHealth Capital Region Week 2025 (September 23–25 at US Pharmacopeia in Rockville, MD) are filling quickly, but select tiers and table options remain available.
Becoming a sponsor positions your brand in front of hundreds of leaders from across the life sciences ecosystem, including C-level executives, government agencies, academic institutions, entrepreneurs, and investors. Sponsors receive visibility across all three signature events, the Forum, Crab Trap, and Investment Conference, along with access to VIP networking and leadership opportunities.
Interested in learning more? Contact Rich Bendis at rbendis@biohealthinnovation.org and Andy Eckert at aeckert@biohealthinnovation.org.
| | Why Research Parks and Innovation Districts are Crucial to University Innovation | Brian Darmody, Chief Strategy Officer at the Association of University Research Parks (AURP) unpacks why physical proximity is non-negotiable for creating startups and corporate partnerships, discusses the different models for building and operating these facilities, and shares crucial advice for any organization looking to build its own community of innovation. | |  | NIH Grant Changes Spark Concern Across the BioHealth Capital Region and Beyond | |
For decades, the National Institutes of Health (NIH) has been the cornerstone of the United States’ biomedical research enterprise. But new policies introduced by the current administration, alongside a proposed 40% cut to ...
| | |
Join Us for the BHCR Forum: BHCR Forum 2025: Where Human and Artificial Intelligence Converge | Be part of the 11th Annual BioHealth Capital Region Forum, September 23–24, 2025, at US Pharmacopeia in Rockville, MD. This year’s theme, Where Human and Artificial Intelligence Converge in the BioHealth Industry, will explore groundbreaking advances shaping the future of healthcare. Connect with industry leaders, investors, government, and academia, and gain insights you can apply to your own organization. Attendance is free thanks to our sponsors, but space is limited — secure your spot today | | |
Technical.ly: Maryland’s stem cell research fund is filling the gap
| |
Brian Jamieson founded Diagnostics Biochips to unlock the inner workings of the brain. Based in Glen Burnie, the medical equipment manufacturing company develops tiny sensors that can be implanted to study electrical brain activity. The goal? To help find cures for neurological diseases like Parkinson’s, epilepsy and others. Diagnostic Biochips also offers....
| | | Connect Capital and Innovation at the BioHealth Capital Region Investment Conference on September 25, 2025 at US Pharmacopeia, Rockville, MD | The Annual BioHealth Capital Region Investment Conference is the premier destination for discovering emerging companies that are redefining what’s possible in life sciences. Taking… | | | Win Over $45,000 in Prizes at the 2025 BHCR Crab Trap Pitch Competition | Applications are now being accepted for the Annual Crab Trap competition on September 24, 2025 during the BioHealth Capital Region Forum, spotlighting groundbreaking early-stage companies in therapeutics, diagnostics, medical devices, and more. Finalists will pitch live in front of investors and industry leaders during BioHealth Capital Region Week. | | | MacroGenics Appoints Eric Risser as President and Chief Executive Officer | |
ROCKVILLE, MD, Aug. 13, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company developing innovative antibody-based therapeutics for the treatment of cancer, today announced that effective as of August 13, 2025...
| | | The BioHealth Capital Region Maintains Top 3 Spot in GEN’s 2025 U.S. Biopharma Cluster Rankings | For the third consecutive year, the BioHealth Capital Region (BHCR), encompassing Maryland, Virginia, and Washington, D.C., has earned a Top 3 position in the highly regarded “Top 10 U.S. Biopharma Clusters” list by Genetic Engineering & Biotechnology News (GEN). | | | Precigen Gets FDA Approval for First Therapy for Recurrent Respiratory Papillomatosis in Adults | Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced that the US Food and Drug Administration (FDA) has approved PAPZIMEOS™ (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP). | | | Virginia Catalyst Awards $2.4 Million in Grants to Support Life Sciences in the Commonwealth | RICHMOND, VA – August 13, 2025 – The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2.4 million in grants to three life and bioscience projects in the Commonwealth of Virginia through a highly-competitive Grant Round 18. | | | TEDCO’s Maryland Innovation Initiative Announces First Round of Baltimore Innovation Initiative Awardees | TEDCO, Maryland’s economic engine for technology companies, announced the first round of the Baltimore Innovation Initiative (BII) Pilot Program awardees, marking an important milestone for the organization. The BII Pilot Program falls under the Maryland Innovation Initiative (MII), fueling innovation and economic impact in the Baltimore region. | | | Ascentage Pharma Gets FDA and EMA Clearance for Phase III Trial of Lisaftoclax in High-Risk MDS | ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization... | | | | | |
